Abstract
Atherosclerosis is an inflammatory disease in which immune mechanisms interact with diverse metabolic risk factors to initiate, propagate and activate lesions in the arterial wall. This process starts and evolves in response to cholesterol accumulation in arterial intima of the large and medium arteries. A number of modalities for inflammatory imaging in the arterial wall are currently in the stages of pre-clinical and clinical development. However, the identification of new targets that are linked to atherosclerosis to allow for dynamic ranges of diagnosis and prognosis still remains a challenge. In this review, we summarize the current status of atherosclerosis imaging aimed at macrophage-related, direct macrophage and non-macrophage as target molecules during different stages of atherogenesis. We also present activated macrophage, biofilm and amyloid fibrils as possible new targets for the development of non-invasive imaging probes to assess atherosclerosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Analytical sciences : the international journal of the Japan Society for Analytical Chemistry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
